SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

FDA Approves Roche’s Gazyva for Primary Membranous Nephropathy

Gazyva/Gazyvaro becomes the first FDA-approved treatment for primary membranous nephropathy.

Related stories